Trials / Completed
CompletedNCT05168436
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal
Preferences Of Patients And Oncologists For The Characteristics Of The Treatment For RCC In Spain And Portugal
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this observational study is to determine patients' and professionals' preferences for the characteristics (attributes) of the treatment for Renal cell carcinoma (RCC) in Spain and Portugal.
Detailed description
This study uses a literature review, qualitative (focus groups) and quantitative methods (discrete-choice experiment, DCE) to determine renal cell carcinoma (RCC) participants and oncologists' preferences. In this clinical trial, the study team will develop a survey consisting of comparisons of hypothetical treatment profiles (scenarios). Scenarios are presented to participants, and each participant chooses the most preferable.
Conditions
Timeline
- Start date
- 2019-08-05
- Primary completion
- 2020-07-13
- Completion
- 2020-07-13
- First posted
- 2021-12-23
- Last updated
- 2021-12-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05168436. Inclusion in this directory is not an endorsement.